{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:36:42Z","timestamp":1762868202832,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:00:00Z","timestamp":1591488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T00:00:00Z","timestamp":1591488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s00774-020-01113-1","type":"journal-article","created":{"date-parts":[[2020,6,7]],"date-time":"2020-06-07T05:02:18Z","timestamp":1591506138000},"page":"819-825","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changing face of medication-related osteonecrosis of the jaw: Sheba Medical Center experience-fifteen years"],"prefix":"10.1007","volume":"38","author":[{"given":"Sara","family":"Whitefield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Towi Sorel","family":"Lazarovici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Sommer-Umansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvina","family":"Friedlander-Barenboim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Yahalom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1621-8103","authenticated-orcid":false,"given":"Noam","family":"Yarom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,7]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"publisher","first-page":"2684924","DOI":"10.1155\/2018\/2684924","volume":"2018","author":"O Di Fede","year":"2018","unstructured":"Di Fede O, Panzarella V, Mauceri R, Fusco V, Bedogni A, Lo Muzio L, Board Sipmo Onj, Campisi G (2018) The dental management of patients at risk of medication-related osteonecrosis of the jaw: new paradigm of primary prevention. Biomed Res Int 2018:2684924. https:\/\/doi.org\/10.1155\/2018\/2684924","journal-title":"Biomed Res Int"},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.oraloncology.2009.10.004","volume":"46","author":"N Yarom","year":"2010","unstructured":"Yarom N, Elad S, Madrid C, Migliorati CA (2010) Osteonecrosis of the jaws induced by drugs other than bisphosphonates\u2014a call to update terminology in light of new data. Oral Oncol 46:e1. https:\/\/doi.org\/10.1016\/j.oraloncology.2009.10.004","journal-title":"Oral Oncol"},{"key":"1113_CR3","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S1470-2045(10)70198-4","volume":"11","author":"P Gimsing","year":"2010","unstructured":"Gimsing P, Carlson K, Turesson I, Fayers P, Waage A et al (2010) Effect of pamidronate 30\u00a0mg versus 90\u00a0mg on physical function in patients with newly diagnosed multiple myeloma A double-blind, randomised controlled trial. Lancet Oncol 11:973\u2013982. https:\/\/doi.org\/10.1016\/S1470-2045(10)70198-4","journal-title":"Lancet Oncol"},{"key":"1113_CR4","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1200\/JCO.2012.47.7901","volume":"31","author":"E Terpos","year":"2013","unstructured":"Terpos E, Morgan G, Dimopoulos MA, Drake MT, Lentzsch S et al (2013) International Myeloma Working Group recommendations for the treatment of multiple myeloma-related bone disease. J Clin Oncol 31:2347. https:\/\/doi.org\/10.1200\/JCO.2012.47.7901","journal-title":"J Clin Oncol"},{"key":"1113_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oooo.2017.09.014","volume":"125","author":"N Yarom","year":"2018","unstructured":"Yarom N, Lazarovici TS, Whitefield S, Weissman T, Wasserzug O, Yahalom R (2018) Rapid onset of osteonecrosis of the jaw in patients switching from bisphosphonates to denosumab. Oral Surg Oral Med Oral Pathol Oral Radiol 125:27\u201330. https:\/\/doi.org\/10.1016\/j.oooo.2017.09.014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"Salvatore L Ruggiero","year":"2014","unstructured":"Ruggiero Salvatore L et al (2014) American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw\u2014update. J Oral Maxillofac Sur 72:1938\u20131956. https:\/\/doi.org\/10.1016\/j.joms.2014.04.031","journal-title":"J Oral Maxillofac Sur"},{"key":"1113_CR7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","volume":"23","author":"F Saad","year":"2012","unstructured":"Saad F, Brown JE, Van Poznak C, Ibrahim T, Stemmer SM, Stopeck AT, Diel IJ, Takahashi S, Shore N, Henry DH, Barrios CH, Facon T, Senecal F, Fizazi K, Zhou L, Daniels A, Carri\u00e8re P, Dansey R (2012) Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 23:1341\u20131347. https:\/\/doi.org\/10.1093\/annonc\/mdr435","journal-title":"Ann Oncol"},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","volume":"63","author":"RE Marx","year":"2005","unstructured":"Marx RE, Sawatari Y, Fortin M (2005) Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567\u20131575. https:\/\/doi.org\/10.1016\/j.joms.2005.07.010","journal-title":"J Oral Maxillofac Surg"},{"key":"1113_CR9","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.oooo.2018.02.003","volume":"125","author":"AA Owosho","year":"2018","unstructured":"Owosho AA, Liang STY, Sax AZ, Wu K, Yom SK, Huryn JM, Estilo CL (2018) Medication-related osteonecrosis of the jaw: An update on the memorial Sloan Kettering cancer center experience and the role of premedication dental evaluation in prevention. Oral Surg Oral Med Oral Pathol Oral Radiol 125:440\u2013445. https:\/\/doi.org\/10.1016\/j.oooo.2018.02.003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1113_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/annonc\/mdr039","volume":"23","author":"AM Vandone","year":"2012","unstructured":"Vandone AM, Donadio M, Mozzati M, Ardine M, Polimeni MA, Beatrice S, Ciuffreda L, Scoletta M (2012) Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Ann Oncol 23:193\u2013200. https:\/\/doi.org\/10.1093\/annonc\/mdr039","journal-title":"Ann Oncol"},{"key":"1113_CR11","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1200\/JCO.19.01186","volume":"37","author":"N Yarom","year":"2019","unstructured":"Yarom N, Shapiro CL, Peterson DE, Van Poznak CH, Bohlke K, Ruggiero SL, Migliorati CA, Khan A, Morrison A, Anderson H, Murphy BA, Alston-Johnson D, Mendes RA, Beadle BM, Beier Jensen S, Saunders DP (2019) Medication-related osteonecrosis of the jaw: Multinational Association of Supportive Care in Cancer\/International Society of Oral Oncology\/American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 37:2270\u20132290. https:\/\/doi.org\/10.1200\/JCO.19.01186","journal-title":"J Clin Oncol"},{"key":"1113_CR12","doi-asserted-by":"publisher","first-page":"1047S","DOI":"10.4065\/81.8.1047","volume":"81","author":"MQ Lacy","year":"2006","unstructured":"Lacy MQ, Dispenzieri A, Gertz MA, Greipp PR, Gollbach KL et al (2006) Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. Mayo Clin Proc 81:1047S\u20131053. https:\/\/doi.org\/10.4065\/81.8.1047","journal-title":"Mayo Clin Proc"},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.joms.2008.11.015","volume":"67","author":"TS Lazarovici","year":"2009","unstructured":"Lazarovici TS, Yahalom R, Taicher S, Elad S, Hardan I, Yarom N (2009) Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients. J Oral Maxillofac Surg 67:850\u2013855. https:\/\/doi.org\/10.1016\/j.joms.2008.11.015","journal-title":"J Oral Maxillofac Surg"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-020-01113-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-020-01113-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,6]],"date-time":"2021-06-06T23:15:19Z","timestamp":1623021319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-020-01113-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,7]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1007\/s00774-020-01113-1","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2020,6,7]]},"assertion":[{"value":"18 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Sara Whitefield declares that she has no conflict of interest. Towi Sorel Lazarovici declares that he has no conflict of interest. Marina Sommer-Umansky declares that she has no conflict of interest. Silvina Friedlander-Barenboim declares that she has no conflict of interest. Ran Yahalom declares that he has no conflict of interest. Noam Yarom declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study, formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}